{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T02:22:31Z","timestamp":1648952551400},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.yrtph.2015.07.024","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T12:29:50Z","timestamp":1438259390000},"page":"401-412","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Carcinogenicity testing of eliglustat in mice and rats"],"prefix":"10.1016","volume":"73","author":[{"given":"Rafif","family":"Dagher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malene","family":"Watzinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Thirion-Delalande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Forster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2015.07.024_bib1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2307\/2532200","article-title":"Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity","volume":"49","author":"Bieler","year":"1993","journal-title":"Biometrics"},{"key":"10.1016\/j.yrtph.2015.07.024_bib2","series-title":"Guidance for Industry: Statistical Aspects of the Design, Analysis, and Interpretation of Chronic Rodent Carcinogenicity Studies of Pharmaceuticals","author":"FDA","year":"2001"},{"issue":"2","key":"10.1016\/j.yrtph.2015.07.024_bib3","first-page":"283","article-title":"Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies","volume":"76","author":"McConnell","year":"1986","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.yrtph.2015.07.024_bib4","series-title":"Long-term and Short-term Screening Assays for Carcinogens: a Critical Appraisal","article-title":"Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments","author":"Peto","year":"1980"},{"issue":"8","key":"10.1016\/j.yrtph.2015.07.024_bib5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1358\/dof.2010.035.08.1505566","article-title":"Eliglustat Tartrate, glucosylceramide synthase inhibitor treatment of type 1 gaucher disease","volume":"35","author":"Shayman","year":"2010","journal-title":"Drugs Future"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230015300337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230015300337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T15:20:13Z","timestamp":1537456813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230015300337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0273230015300337"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2015.07.024","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carcinogenicity testing of eliglustat in mice and rats","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2015.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}